相关实验视频

Updated: Jun 13, 2025

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

缺失的调节效应和病毒触发器被探索为儿童发作的喘

¹Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

|September 12, 2024

概括

在特定的细胞状态下,儿童喘的遗传风险可能会被忽视. 呼吸道上皮细胞的犀牛病毒激活揭示了这些细胞如何影响喘遗传易感性.

科学领域:

免疫学免疫学免疫学
遗传学是一个遗传学.
呼吸系统医学呼吸系统医学

背景情况:

遗传倾向在儿童发作的喘中起着重要作用.
目前对喘遗传风险的理解可能是不完整的,因为没有特征的调节效应.
特定的细胞环境及其对环境因素的反应对疾病发展至关重要.

研究的目的:

研究呼吸道上皮细胞如何在犀利病毒激活后导致儿童发作喘的遗传易感性.
识别和描述喘遗传风险的细胞状态特异性调节效应.
突出考虑各种细胞状态在理解喘病变发生过程中的重要性.

主要方法:

对气道上皮细胞中的基因表达和调节网络的分析.
使用犀牛病毒感染模型来模仿环境触发因素.
将遗传风险数据与细胞状态特定的分子概况集成.

主要成果:

空气道上皮细胞,特别是当被犀利病毒激活时,表现出调节效应,影响对喘的遗传易感性.
确定了特定的细胞状态,在此之前隐藏的与喘相关的遗传调节效应变得明显.
这项研究提供了关于病毒感染,细胞反应和儿童喘遗传倾向之间的相互作用的见解.

结论:

缺少喘遗传学的遗传性可以归因于特定细胞状态中隐藏的调节效应.
了解细胞状态特异性反应,例如由呼吸道上皮质中的鼻病毒诱导的反应,对于全面了解喘遗传学至关重要.
未来的研究应该探索多样化的细胞状态,以充分阐明喘的遗传结构.

更多相关视频

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

相关概念视频

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...